NeoGenomics Stock (NASDAQ: NEO) stock price, news, charts, stock research, profile.
Open | $14.780 |
Close | - |
Volume / Avg. | 94.340K / 886.192K |
Day Range | 14.600 - 14.900 |
52 Wk Range | 11.030 - 21.220 |
Market Cap | $1.904B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 47 |
Short Interest | 8.27% |
Days to Cover | 7.4 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of NeoGenomics (NASDAQ: NEO) through any online brokerage.
Other companies in NeoGenomics’s space includes: CVS Health (NYSE:CVS), Chemed (NYSE:CHE), Hims & Hers Health (NYSE:HIMS), Privia Health Gr (NASDAQ:PRVA) and Premier (NASDAQ:PINC).
The latest price target for NeoGenomics (NASDAQ: NEO) was reported by BTIG on Thursday, May 2, 2024. The analyst firm set a price target for 21.00 expecting NEO to rise to within 12 months (a possible 40.85% upside). 21 analyst firms have reported ratings in the last year.
The stock price for NeoGenomics (NASDAQ: NEO) is $14.91 last updated May 20, 2024 at 4:00 PM EDT.
There are no upcoming dividends for NeoGenomics.
NeoGenomics’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for NeoGenomics.
NeoGenomics is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.